Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Coloplast A/S Sponsored ADR (CLPBY : OTC)

• Company Description    Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark. Number of Employees: 17,156

• Price / Volume Information    Yesterday's Closing Price: $7.81 Daily Weekly Monthly 20 Day Moving Average: 380,363 shares Shares Outstanding: 2,253.67 (millions) Market Capitalization: $17,601.16 (millions) Beta: 0.26 52 Week High: $11.44 52 Week Low: $7.83 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.95% -11.09% 12 Week -16.65% -18.99% Year To Date -8.12% -0.73%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL HOLTEDAM 1-3 - HUMLEBAEK,G7 3050 DNK ph: 45-4911-1111 fax: - dkadim@coloplast.com http://www.coloplast.com

• General Corporate Information    Officers Kristian Villumsen - Chief Executive Officer Jette Nygaard-Andersen - Chairman Niels Peter Louis-Hansen - Deputy Chairman Anders Lonning-Skovgaard - Chief Financial Officer and Executive Vice Preside Anders Lonning-Skovgaard - Executive Vice President Peer Information Coloplast A/S Sponsored ADR (ABMD) Coloplast A/S Sponsored ADR (DMDS) Coloplast A/S Sponsored ADR (CPWY.) Coloplast A/S Sponsored ADR (EQUR) Coloplast A/S Sponsored ADR (ECIA) Coloplast A/S Sponsored ADR (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 19624Y200 SIC: 3842 Fiscal Year Fiscal Year End: September Last Reported Quarter: 12/01/25 Next Expected EPS Date: 02/06/26 Share - Related Items Shares Outstanding: 2,253.67 Most Recent Split Date: (:1) Beta: 0.26 Market Capitalization: $17,601.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 4.51% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.35 Current Fiscal Year EPS Consensus Estimate: $0.39 Payout Ratio: 0.31 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.13 Estmated Long-Term EPS Growth Rate: 25.94% Last Dividend Paid: 12/08/2025 - $0.18 Next EPS Report Date: 02/06/26

• Fundamental Ratios P/E Current FY Estimate: 19.86 Trailing 12 Months: 26.93 PEG Ratio: 0.77 Price Ratios Price/Book: 7.37 Price/Cash Flow: 21.78 Price / Sales: 4.17 EPS Growth vs. Year Ago Period: 42.86% vs. Previous Quarter: 42.86% Sales Growth vs. Year Ago Period: 9.24% vs. Previous Quarter: 0.71% ROE 12/31/25 - - 09/30/25 - 24.99 06/30/25 - 24.67 ROA 12/31/25 - - 09/30/25 - 8.38 06/30/25 - 8.52 Current Ratio 12/31/25 - - 09/30/25 - 1.61 06/30/25 - 1.00 Quick Ratio 12/31/25 - - 09/30/25 - 1.00 06/30/25 - 0.64 Operating Margin 12/31/25 - - 09/30/25 - 14.35 06/30/25 - 14.74 Net Margin 12/31/25 - - 09/30/25 - 13.01 06/30/25 - 14.61 Pre-Tax Margin 12/31/25 - - 09/30/25 - 22.09 06/30/25 - 22.23 Book Value 12/31/25 - - 09/30/25 - 1.06 06/30/25 - - Inventory Turnover 12/31/25 - - 09/30/25 - 2.39 06/30/25 - 2.43 Debt-to-Equity 12/31/25 - - 09/30/25 - 1.20 06/30/25 - 1.01 Debt-to-Capital 12/31/25 - - 09/30/25 - 54.55 06/30/25 - 50.18

Powered by Zacks Investment Research ©